Stay updated with breaking news from Ascletis Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Liver Meeting® 2023 showcasing the beneficial shift in lipid profile in denifanstat-treated patients End-of-Phase 2 meeting with U.S. Food and Drug Administration expected in first half of...
Sagimet Biosciences Inc. (SGMT) expects to raise $75 million in an IPO on Friday, July 14th, IPO Scoop reports. The company plans to issue 4,700,000 shares at a price of $15.00-$17.00 per share. Sagimet Biosciences Inc. has a market cap of $344.8 million. Goldman Sachs, TD Cowen, Piper Sandler and JMP Securities (a CITIZENS Company) […]
Sagimet Biosciences Inc. (SGMT) expects to raise $75 million in an initial public offering on Friday, July 14th, IPO Scoop reports. The company will be issuing 4,700,000 shares at a price of $15.00-$17.00 per share. Sagimet Biosciences Inc. has a market-cap of $344.8 million. Goldman Sachs, TD Cowen, Piper Sandler and JMP Securities (a CITIZENS […]
Sagimet Biosciences Inc. (SGMT) plans to raise $75 million in an initial public offering (IPO) on Friday, July 14th, IPO Scoop reports. The company will issue 4,700,000 shares at $15.00-$17.00 per share. The company has a market cap of $344.8 million. Goldman Sachs, TD Cowen, Piper Sandler and JMP Securities (a CITIZENS Company) served as […]